This info showed up on Sheff's thread.It has not come up on Schwab News yet. ZGNX..Zogenix (ZGNX +8.1%) moves up after saying the FDA has scheduled two days of hearings February 7-8 after receiving "comments, petitions, and informal inquiries concerning the extent to which opioid drugs should be used in the treatment of pain." Last week A panel of non-FDA medical experts shot down ZGNX's Zohydro, a hydrocodone pill for chronic pain.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.